Navigation Links
Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial
Date:5/26/2009

eeding from a coiled aneurysm in the first five years, fewer coiled patients died at five years, and there have been no observed hemorrhages from a coiled aneurysm in these patients after five years."

"The extraordinary work by Drs. Molyneux and Kerr and the ISAT investigators represents a milestone in the evolution of treatment for cerebral aneurysms," said Mark Paul, President, Boston Scientific Neurovascular. "The data from ISAT over the last six years have informed the worldwide neurovascular community and helped physicians better determine the best treatment options for patients suffering from a ruptured aneurysm."

The primary objective of ISAT was to determine whether endovascular treatment reduced the rates of patient death or dependency at one year compared with surgical treatment. The trial, supported by the U.K.'s Medical Research Council (MRC), began as a pilot study in 1994 and enrolled 2,143 patients at 43 neurosurgical centers who were randomly assigned to coiling or clipping. Patients were primarily treated with the early generation of Boston Scientific's GDC(R) Coils, some as far back as 14 years when technology, angiographic imaging equipment and physician experience differed significantly from today. One-year results reported in 2002 demonstrated a 24 percent relative risk reduction in death or dependency in patients treated with endovascular coiling compared to surgical clipping, which is consistent with five-year results.

"ISAT has required the dedication of doctors, nurses, trial staff, patients and their relatives over many years, and we are extremely grateful to them all," said Dr. Molyneux. "The positive trial results should reassure patients and physicians that treatment with endovascular coiling is safe in the short term while also providing a long-term benefit of lower death risk compared to surgical intervention. The latest data continue to support the general shift toward coili
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease
2. Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
3. Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
4. Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientifics TAXUS(R) Liberte(R) Stent
5. Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine
6. Clinical Data Reinforce Safety and Efficacy of Boston Scientifics Two Drug- Eluting Stent Platforms
7. New England Journal of Medicine Publishes Results from Boston Scientifics Landmark SYNTAX(TM) Trial
8. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
9. Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
10. Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientifics Next-Generation Taxus Liberte Stent
11. Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... 14, 2014 The legalization of medical and ... well as a new economic driver – that has ... out the right response to the will of the ... At a National Press Club Newsmakers news ... leading experts in the area of marijuana legalization will ...
(Date:7/14/2014)... 14 de julio de 2014 /PRNewswire-HISPANIC PR WIRE/ -- ... Barry Epling , presidente de la junta directiva, ... la Compañía. El señor Epling es el dueño de ... la licencia de su formulación, sus propiedades intelectuales y ... apoyo financiero. "El señor Gerald Epling ...
(Date:7/14/2014)... PARK, Colo. , July 14, 2014 /PRNewswire-iReach/ -- Harmony ... center, located in Estes Park , will ... July 18, 2014 at 10:00 am on Harmony,s campus. The ... The building is part of Harmony,s $10 million ... capacity to address the growing and complex addiction rates in ...
Breaking Medicine Technology:NPC Newsmaker Program: Interpreting smoke signals from the marijuana skirmish line 2BioAdaptives se prepara para el próximo paso 2BioAdaptives se prepara para el próximo paso 3Harmony Foundation Breaking Ground on Addiction Health Center 2
... 8, 2011 /PRNewswire-Asia/ -- To thank customers for their ... infrared thermometers , heart beat watches, blood pressure monitors ... has decided to offer these products with discounts ... market needs and offer more suitable products to customers, ...
... 2011 SANYO North America Corporation (SANYO) ... Station (CPWS), an integrated, stand-alone solution for GMP compliant ... therapies for research use, has been installed at the ... first installation of the CPWS, as well as marking ...
Cached Medicine Technology:SANYO Installs First Cell Processing Work Station in the United States at University of Alabama at Birmingham 2SANYO Installs First Cell Processing Work Station in the United States at University of Alabama at Birmingham 3
(Date:7/14/2014)... “Metabolomics Market by Technique (Gas ... Resonance Spectroscopy, Mass Spectrometry, by Application (Biomarker ... Cardiology) - Global Forecast to 2019” analyzes ... and opportunities in North America, Europe, Asia-Pacific, ... Browse 80 market data tables and 7 ...
(Date:7/14/2014)... Tel Aviv University,s Sackler Faculty of Medicine and ... Tel Hashomer, documented the exceptional creativity of Parkinson,s ... Behavioral Neuroscience. Since then, she has conducted the ... Parkinson,s disease and artistic inclination. , That empirical ... Neurology , definitively demonstrates that Parkinson,s patients are ...
(Date:7/14/2014)... Washington D.C., July 14, 2014 A recent study ... Journal of the American Academy of Child and Adolescent ... to the age of onset criterion for diagnosis of ... criterion for ADHD, previously set at 7 in DSM-IV, ... age of onset is now set at 12, rather ...
(Date:7/14/2014)... Documented Legacy , a mobile personal historian ... its first military memoir about a World War II veteran, ... 1943 and 19 months as a prisoner of war before ... American dream. , From the Top Turret: A Memoir ... is a true life story of Gerard Caporaso’s courage, ...
(Date:7/14/2014)... 2014 Seven promising startup companies ... problems have been accepted into the University ... (DHA). , The awardees were selected from ... process. They include Biomeme, Fitly, Life Patch, Curbside ... France) and Pulse InfoFrame (from Canada) —both of ...
Breaking Medicine News(10 mins):Health News:Metabolomics Market Worth $2,100 Million by 2019 - New Report by MarketsandMarkets 2Health News:Metabolomics Market Worth $2,100 Million by 2019 - New Report by MarketsandMarkets 3Health News:Metabolomics Market Worth $2,100 Million by 2019 - New Report by MarketsandMarkets 4Health News:Proof: Parkinson's enhances creativity 2Health News:Proof: Parkinson's enhances creativity 3Health News:Mount Laurel-based Documented Legacy to Release Military Memoir of World War II Air Force Vet Who Survived Black Thursday Crash 2Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 2Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 3Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 4
... all experienced the strong heartbeat that accompanies emotions such as ... these emotions be used to combat heart failure? Results of ... Research present a strong case. In ... found that two experimental drugs have the potential to restore ...
... (PHILADELPHIA) Previous studies have shown that antiviral treatment reduces ... chronic hepatitis B (CHB). But now, researchers from the ... are reporting that the antiviral therapy also prevents recurrence ... standard of care for patients with HCC is local ...
... June 2010 Elsevier, a world-leading publisher of scientific, ... that VIVO has begun a pilot project to evaluate ... used to populate institutional VIVO instances. The pilot project, ... University of Florida, utilizes a Scopus Custom Data dataset ...
... ANGELES (June 24, 2010) The nerve cell-damaging plaque ... also builds up in the retinas of the eyes ... the prospect that noninvasive optical imaging of the eyes ... the disease, according to new research. Scientists discovered ...
... today that TWAS has received the 2010 Premio Feltrinelli. ... have made outstanding contributions to knowledge or to addressing ... to as Italy,s Nobel prize. TWAS, as noted ... for its "unprecedented accomplishments of high moral and humanitarian ...
... 23, 2010 -- The Accreditation Council for Graduate ... resident training program standards today presented a comprehensive ... supervision and duty hours to better match residents, ... graduate medical education and quality patient care in ...
Cached Medicine News:Health News:Targeting flight-or-fight hormone response to combat heart failure 2Health News:Targeting flight-or-fight hormone response to combat heart failure 3Health News:Silencing hepatitis B virus prevent recurrence of liver cancer 2Health News:VIVO utilizing Scopus custom data 2Health News:Hallmark Alzheimer's disease changes found in retinas of humans and imaged in live animals 2Health News:Hallmark Alzheimer's disease changes found in retinas of humans and imaged in live animals 3Health News:TWAS awarded Premio Feltrinelli 2Health News:ACGME task force proposes graduated duty hour and supervision standards 2Health News:ACGME task force proposes graduated duty hour and supervision standards 3Health News:ACGME task force proposes graduated duty hour and supervision standards 4Health News:ACGME task force proposes graduated duty hour and supervision standards 5
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: